For 27 years, BlueMatrix has helped investment research get from an analyst’s desk to a client’s screen. Its next problem is stranger: keeping the analyst’s name attached when the reader is a machine.
A healthcare research firm built its edge by reaching people conventional panels struggled to find. Its next challenge is making years of accumulated research easier to use.
The London company spent 16 years assembling the plumbing of modern research. Now it is wiring that portfolio into AI - without asking scientists to hand the keys to a chatbot.